SRT2183 INHIBITS OSTEOCLAST FUSION VIA AMPK IN A SIRT1 INDEPENDENT MANNER

被引：0
|
作者：
Gurt, Irina [1 ]
Artsi, Hanna [1 ]
Cohen-Kfir, Einav [1 ]
Hamdani, Gilad [1 ]
Ben-Shalom, Gal [1 ]
Dresner-Pollak, Rivka [1 ]
机构：
[1] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
来源：
OSTEOPOROSIS INTERNATIONAL | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [1] SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
    Pacholec, Michelle
    Bleasdale, John E.
    Chrunyk, Boris
    Cunningham, David
    Flynn, Declan
    Garofalo, Robert S.
    Griffith, David
    Griffor, Matt
    Loulakis, Pat
    Pabst, Brandon
    Qiu, Xiayang
    Stockman, Brian
    Thanabal, Venkataraman
    Varghese, Alison
    Ward, Jessica
    Withka, Jane
    Ahn, Kay
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) : 8340 - 8351
  • [2] SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183
    Huber, Julie L.
    McBurney, Michael W.
    DiStefano, Peter S.
    McDonagh, Thomas
    [J]. FUTURE MEDICINAL CHEMISTRY, 2010, 2 (12) : 1751 - 1759
  • [3] The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells
    Gurt, Irina
    Artsi, Hanna
    Cohen-Kfir, Einav
    Hamdani, Gilad
    Ben-Shalom, Gal
    Feinstein, Ben
    El-Haj, Madi
    Dresner-Pollak, Rivka
    [J]. PLOS ONE, 2015, 10 (07):
  • [4] Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/CREB pathway
    Wang, Si-wei
    Wang, Wen
    Sheng, Hao
    Bai, Yong-feng
    Weng, Yuan-yuan
    Fan, Xue-yu
    Zheng, Fang
    Zhu, Xin-tian
    Xu, Zheng-cai
    Zhang, Feng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [5] Novel SIRT1 Agonists, SRT501 and SRT2183, Induce Expression of DNA Repair Genes and Apoptosis of Ph- Acute Lymphoblastic Leukemia Cells Alone and in Combination with the HDAC Inhibitor LBH589.
    Scuto, Anna
    Kirschbaum, Mark
    Cermak, Jennifer M.
    Atadja, Peter
    Jove, Richard
    [J]. BLOOD, 2009, 114 (22) : 1199 - 1199
  • [6] SRT2104, A NOVEL AND SELECTIVE SMALL MOLECULE SIRT1 ACTIVATOR, INHIBITS DSS-INDUCED COLITIS IN A SIRT1-DEPENDENT MANNER
    Ellis, J. L.
    Gagne, D. J.
    Suri, V.
    Cermak, J. M.
    Lyng, G. D.
    Guarente, L. P.
    Vlasuk, G. P.
    [J]. INFLAMMATION RESEARCH, 2011, 60 : 240 - 241
  • [7] BDMC protects AD in vitro via AMPK and SIRT1
    Xu, Chenlin
    Xiao, Zijian
    Wu, Heng
    Zhou, Guijuan
    He, Duanqun
    Chang, Yunqian
    Li, Yihui
    Wang, Gang
    Xie, Ming
    [J]. TRANSLATIONAL NEUROSCIENCE, 2020, 11 (01) : 319 - 327
  • [8] Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1
    Sun, Yan
    Li, Jia
    Xiao, Na
    Wang, Meng
    Kou, Junping
    Qi, Lianwen
    Huang, Fang
    Liu, Baolin
    Liu, Kang
    [J]. PHARMACOLOGICAL RESEARCH, 2014, 89 : 19 - 28
  • [9] Sirt1 inhibits gouty arthritis via activating PPARγ
    Juan Wang
    Guangliang Chen
    Liangjing Lu
    Hejian Zou
    [J]. Clinical Rheumatology, 2019, 38 : 3235 - 3242
  • [10] Sirt1 inhibits gouty arthritis via activating PPARγ
    Wang, Juan
    Chen, Guangliang
    Lu, Liangjing
    Zou, Hejian
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (11) : 3235 - 3242
12345